These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3830247)

  • 1. Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.
    Gachályi B; Vas A; Csillag K; Nagy B; Kocsis F; Káldor A
    Eur J Clin Pharmacol; 1987; 31(5):613-5. PubMed ID: 3830247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of cimetidine on antipyrine metabolism.
    Piekoszewski W; Rutkowska A; Brandys J
    Pol J Pharmacol; 1993; 45(4):421-9. PubMed ID: 8118484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on microsomal drug metabolism in man.
    Puurunen J; Sotaniemi E; Pelkonen O
    Eur J Clin Pharmacol; 1980 Aug; 18(2):185-7. PubMed ID: 7428801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between antipyrine metabolism and acetylation phenotype in health and chronic liver diseases.
    el-Yazigi A; Raines DA; Wahab FA; Sieck JO; Ernst P; Ali H; Dossing M
    J Clin Pharmacol; 1995 Jun; 35(6):615-21. PubMed ID: 7665722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
    Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
    Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The acetylator phenotype affects the antipyrine metabolism inhibiting action of cimetidine].
    Gachályi B; Vas A; Csillag K; Nagy B; Kocsis F; Káldor A
    Orv Hetil; 1986 Jun; 127(25):1495-7. PubMed ID: 3523384
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    Shaw PN; Tseti J; Warburton S; Adedoyin A; Houston JB
    Drug Metab Dispos; 1986; 14(2):271-6. PubMed ID: 2870906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects.
    Feely J; Pereira L; Guy E; Hockings N
    Br J Clin Pharmacol; 1984 Jan; 17(1):77-81. PubMed ID: 6691891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine-induced reduction in gastrointestinal absorption of antipyrine and rate constants for formation of its metabolites.
    Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1984 May; 35(5):568-75. PubMed ID: 6713770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine impairs clearance of antipyrine and desmethyldiazepam in the elderly.
    Divoll M; Greenblatt DJ; Abernethy DR; Shader RI
    J Am Geriatr Soc; 1982 Nov; 30(11):684-9. PubMed ID: 6813365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK; Ene MD; Parker G; Roberts CJ
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.
    Teunissen MW; Kleinbloesem CH; de Leede LG; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(6):681-4. PubMed ID: 4065192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
    Buters JT; Reichen J
    Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.